Biogen and Eisai say Alzheimer’s treatment slowed disease progression, backing amyloid theory
The drug, dubbed BAN2401, slowed declines associated with Alzheimer’s disease by 30 percent at its highest dose in the trial, compared with placebo, after 18 months.
from Top News & Analysis https://ift.tt/2OiTbrB
from Top News & Analysis https://ift.tt/2OiTbrB
0 Response to "Biogen and Eisai say Alzheimer’s treatment slowed disease progression, backing amyloid theory"
Post a Comment